Corbus Pharmaceuticals updates investor presentation; no material changes disclosed

Corbus Pharmaceuticals Holdings, Inc.

Filed updated corporate presentation dated February 2, 2024, as Exhibit 99.1.
Presentation title slide only provided; no specific operational or financial updates included.
No new drug pipeline milestones, financial results, or strategic changes announced.
Routine disclosure under Regulation FD; presentation available on company website.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.